Verification Study of Ciclosporin for Atopic Dermatitis

NCT00232076 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Severe Atopic Dermatitis

Interventions

DRUG: ciclosporin

Sponsor

Novartis Pharmaceuticals